WIM
INMB icon

Westside Investment Management’s INmune Bio INMB Stock Holding History

Westside Investment Management’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122K Sell
108,300
-650
-0.6% -$926 0.02% 369
2025
Q4 		$170K Buy
108,950
+5,500
+5% +$9.81K 0.03% 306
2025
Q3 		$214K Buy
103,450
+82,075
+384% +$188K 0.03% 273
2025
Q2 		$49.4K Sell
21,375
-67,825
-76% -$498K 0.01% 460
2025
Q1 		$697K Sell
89,200
-775
-0.9% -$6.16K 0.15% 133
2024
Q4 		$420K Buy
89,975
+18,660
+26% +$97.3K 0.09% 162
2024
Q3 		$384K Buy
71,315
+25,975
+57% +$185K 0.08% 168
2024
Q2 		$400K Buy
45,340
+10,950
+32% +$108K 0.09% 158
2024
Q1 		$404K Sell
34,390
-7,475
-18% -$90.3K 0.1% 159
2023
Q4 		$471K Buy
41,865
+325
+0.8% +$2.72K 0.12% 146
2023
Q3 		$281K Sell
41,540
-700
-2% -$5.8K 0.08% 178
2023
Q2 		$384K Buy
42,240
+5,135
+14% +$41.2K 0.11% 160
2023
Q1 		$240K Buy
37,105
+6,715
+22% +$54.1K 0.07% 190
2022
Q4 		$192 Buy
30,390
+150
+0.5% +$1.06K ﹤0.01% 322
2022
Q3 		$187 Buy
30,240
+100
+0.3% +$878 ﹤0.01% 321
2022
Q2 		$266 Buy
30,140
+3,750
+14% +$27.9K ﹤0.01% 310
2022
Q1 		$222 Buy
26,390
+18,590
+238% +$167K ﹤0.01% 319
2021
Q4 		$79 Buy
+7,800
New +$115K ﹤0.01% 364

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Westside Investment Management's INMB Position: Q1 2026 in Review

Westside Investment Management reduced its INmune Bio (INMB) stake by 0.6% in Q1 2026, selling an estimated $926 and leaving 108,300 shares worth $122K. The position accounts for 0.02% of the portfolio, ranked #369.

Westside Investment Management first reported a position in INMB in Q4 2021 and has held it in 18 quarters since. The position peaked at $697K in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Westside Investment Management held 108,300 shares of INmune Bio worth $122K as of Q1 2026.
  • Westside Investment Management sold 650 INmune Bio shares in Q1 2026, an estimated $926.
  • INmune Bio made up 0.02% of Westside Investment Management's portfolio in Q1 2026, its #369 holding.
  • Westside Investment Management first reported a position in INmune Bio in Q4 2021 and has held it in 18 quarters since.
  • Westside Investment Management's INmune Bio position peaked at $697K in Q1 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Westside Investment Management's 13F filing for Q1 2026, filed 4 May 2026.